Did you know a prosthesis has been developed that can take the place of a cortical bone allograft in some dogs with appendicular
osteosarcoma? Or that dogs with osteosarcoma can also be helped through bone transport osteogenesis—a technique in which healthy
bone is slowly moved into the site of a defect to form regenerate bone there?
In this month's symposium, you'll find fascinating reading about these promising therapies, as well as the latest on more
conventional treatments for dogs or cats with mast cell tumors, lymphoma, and osteosarcoma.
We thank the symposium's authors—Drs. Timothy M. Fan, Louis-Philippe de Lorimier, Carl T. Jehn, James P. Farese, Daniel D.
Lewis, Nicole Ehrhart, and Charles A. Kuntz—for these thoroughly researched articles. We know it's hard for busy practitioners
to keep up with their continuing education needs. But authors like these make your job easier: After reading these articles
you'll be up-to-date on the treatments available—and those on the horizon—for these common cancerous tumors.
These articles are aimed at general practitioners. In selecting which specific topics to cover, Drs. Fan and de Lorimier were
guided, in part, by suggestions from our Practitioner Advisory Board, who shared with the authors practitioners' most common
questions and concerns on how to treat mast cell tumors and lymphoma.
Our board members' input and expertise are invaluable to this journal. This month, we're honored to welcome two new members
to our Editorial Advisory Board: Dr. Karen A. Moriello from the University of Wisconsin and Dr. Keith A. Hnilica from The
University of Tennessee. These respected dermatologists are familiar names in these pages, particularly Dr. Moriello, a regular
contributor to "Dermatology Challenge" and "Dermatology Update," a department she originated.
Dr. Dru Forrester and Dr. Linda Medleau are retiring from the Editorial Advisory Board after years of service. Both have played
important roles in reviewing and writing for Veterinary Medicine. We thank them for their contributions in the past and for their continued participation in the future.